Actively Recruiting
Prospective Study to Evaluate Streptococcus Pneumoniae Serotypes Prevalence in Community Acquired Pneumonia Using a Urinary Kit
Led by Chinese University of Hong Kong · Updated on 2025-02-12
1800
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand how common different types of pneumococcus pneumoniae are in adults hospitalized with community-acquired pneumonia (CAP). It is a non-interventional, observational study conducted at a single center. The study focuses on identifying pneumococcal serotypes using a urinary antigen test to better inform treatment approaches. Participants who are admitted to medical wards with suspected pneumonia, chest infection, or fever will be invited to join. Those who consent will provide a urine sample of about 40 ml. This urine will be tested locally and then sent to a commercial lab for detecting pneumococcal pneumoniae and determining its serotypes using a urinary antigen assay. Patients will continue to receive usual care from their clinical teams, with the study team only collecting urine samples and not interfering with treatment. Any positive findings will be shared with clinical teams for appropriate management. During the study, participants will be involved mainly in providing urine samples for testing. Researchers will track the presence and types of pneumococcal bacteria using these samples over two years. The study will observe patients' data without altering their treatment and aims to determine the prevalence of pneumococcal serotypes in hospitalized adults with CAP. The total participation time varies depending on hospital admission and care.
CONDITIONS
Brief Title
Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Admitted with signs and symptoms suggestive of pneumonia
You will not qualify if you...
- Pneumonia acquired 48 hours or more after hospital admission (nosocomial pneumonia)
- Pneumonia already known to be caused by pathogens other than pneumococcus pneumoniae
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - During hospital stay
Participants provide a urine sample for testing to detect pneumococcal pneumoniae and determine serotypes using a urinary antigen assay.
1 visit (sample collection)
Duration - 2 years
Participants are observed for up to 2 years to determine the prevalence of pneumococcal serotypes in adults hospitalized with community acquired pneumonia.
No additional visits; data collected through medical records
Trial Site Locations
Total: 1 location
1
Department of Medicine and Therapeutics, Prince of Wales Hospital, CUHK
Shatin, Hong Kong
Actively Recruiting
Research Team
K
K W To
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here